[1] Orfanos CE, Zouboulis CC, Almond-Roesler B, et al. Current use and future potential role of retinoids in dermatology[J]. Drugs,1997,53:358-88. [2] Soprano KJ, Qin P, Soprano KJ. Retinoic acid receptors and cancer[J]. Annu Rev Nutr, 2004, 24: 201-21. [3] Cincinelli R, Dallavalle S, Merlini L, et al. A novel atypical retinoid endowed with proapoptotic and antitumor activity[J]. J Med Chem,2003, 46(6): 909. [4] Xu XC, Wong WY, Goldberg L, et al. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis[J].Cancer Res, 2001, 61(11): 4306-10. [5] Kao SY, Tu HF, Chang KW, et al. The retinoic acid receptor-beta(RAR-beta) mRNA expression in the oral squamous cell carcinoma associated with betel quid use[J]. J Oral Pathol Med, 2002,31 (4):220-6. [6] OrlandiA, BianchiL, CostanzoA, et al. Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene[J]. J Invest Dermatol, 2004, 122(4): 1037. [7] Emionite L, Galmozzi F, Raffo P, et al. Retinoids and malignant melanoma: a pathway of proliferation inhibition on SK MEL28 cell line[J]. Anticancer Res, 2003, 23(1A): 13. [8] Holmes WF, Soprano DR, Soprano KJ. Elucidation of molecular events mediating induction of apoptosis by synthetic retinoids using a CD437-resistant ovarian carcinoma cell line[J]. J Biol Chem,2002, 277(47): 45408-19. [9] Zhang Y, Dawson MI, Mohammad R, et al. Induction ofapoptosis of human B-CLL and ALL cells by a novel retinoid and its nonretinoidal analog[J]. Blood, 2002, 100(8): 2917-25. [10] Simoni D, Tolomeo M. Retinoids, apoptosis and cancer[J]. ’Curr Pharm Des, 2001, 7(17): 1823-37. [11] Waliszewski P, Waliszewska M, Godon N, et al. Retinoid signaling in immortalized and carcinoma-derived human uroepithelial cells[J]. Mol Cell Endocrinol, 1999, 148(1-2): 55-65. [12] Schimerlik MI, Peterson VJ, Hobbs PD, et al. Kinetic and thermodynamic analysis of 9-cis-retinoic acid binding to retinoid X receptor alpha[J]. Biochemistry, 1999, 38(21): 6732-40. [13] Alvarez R, Vega MJ, Kammerer S, et al. 9-cis-retinoic acid analogues with bulky hydrophobic rings: new RXR-selective agonists[J].Bioorg Med Chem Lett, 2004,14(24): 6117-22 [14] Schoff PK, Ankdey GT. Effects of methoprene, its metabolites, and breakdown products on retinoid-activated pathways in transfected cell lines[J]. Environ Toxicol Chem, 2004, 23(5): 1305-10. |